Joan Clària
Grupo de investigación
- Inflamación y enfermedad hepática Group leader (R4)
Publicaciones destacadas
-
Leukocytes from obese individuals exhibit an impaired SPM signature
Autores: López-Vicario C, Titos E, Walker ME, Alcaraz-Quiles J, Casulleras M, Durán-Güell M, Flores-Costa R, Pérez-Romero N, Forné M, Dalli J, Clària J .Referencia: Faseb Journal 2019; 33(6):7072-7083. -
Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis
Autores: Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).Referencia: Hepatology 2019; 69(4):1686-1701. -
Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome
Autores: Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J.Referencia: Journal Of Leukocyte Biology 2019; 105(1):25-36. -
Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis
Autores: Alcaraz-Quiles J; Casulleras M; Oettl K; Titos E; Flores-Costa R; Duran-Güell M; López-Vicario C; Pavesi M; Stauber R; Arroyo V; Clària J.Referencia: Hepatology 2018; 68(5):1937-1952. -
Acute-On-Chronic Liver Failure, Human Serum Albumin and Immune-Modulation: The Beginning of an Exciting Adventure.
Autores: Arroyo V, Clària J .Referencia: Clinical Gastroenterology And Hepatology 2018; 16(5):633-636. -
The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis
Autores: Flores-Costa R; Alcaraz-Quiles J; Titos E; López-Vicario C; Casulleras M; Duran-Güell M; Rius B; Diaz A; Hall K; Shea C; Sarno R; Currie M; Masferrer J; Clària J.Referencia: British Journal Of Pharmacology 2018; 175(6):953-967. -
Pro-resolving actions of SPM in adipose tissue biology
Autores: Clària J; López-Vicario C; Rius B; Titos E.Referencia: MOLECULAR ASPECTS OF MEDICINE 2017. -
Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals
Autores: Lopez-Vicario, Cristina; Rius, Bibiana; Alcaraz-Quiles, Jose; Gonzalez-Periz, Ana; Isabel Martinez-Puchol, Ana; Casulleras, Mireia; Duran-Guell, Marta; Ibarzabal, Ainitze; Corcelles, Ricard; Laguna-Fernandez, Andres; Back, Magnus; Titos, Esther; Claria, Joan.Referencia: Scientific Reports (Nature Publisher Group) 2017; 7(1):15724-. -
Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.
Autores: Alcaraz-Quiles J, Titos E, Casulleras M, Pavesi M, López-Vicario C, Rius B, Lopategi A, de Gottardi A, Graziadei I, Gronbaek H, Ginès P, Bernardi M, Arroyo V, Clària J .Referencia: HEPATOLOGY 2017. -
The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray
Autores: Claria, Joan; Arroyo, Vicente; Moreau, Richard;.Referencia: Journal Of Immunology 2016.
Proyectos destacados
-
Mecanismos moleculares determinantes de la resolución inadecuada de la inflamación en tejido adiposo obeso. Nuevas oportunidades en la prevención de comorbilidades metabolicas.
Financiador: UB, IDIBAPS (Sede); Ministerio de Economía y Competitividad ; Hospital Clinic de Barcelona (Participante)Código: SAF 15/63674-RDuración: 01/01/2015 - 31/12/2018 -
Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent mechanisms of disease
Financiador: Consorcio CIBER del área de Enfermedades Hepáticas y Digestivas (CIBEREHD) (Sede); Ministerio de Economía y Competitividad ; Hospital Clinic de Barcelona (Participante)Duración: 01/01/2015 - 31/12/2017